Last year, Salesforce, the company best known for its cloud sales support software (and Slack), spearheaded a project called ProGen to design proteins using generative AI. A research moonshot, ProGen could -- if brought to market -- help uncover medical treatments more cost effectively than traditional methods, the researchers behind it claimed in a January 2023 blog post. ProGen culminated in research published in the journal Nature Biotech showing that the AI could successfully create the 3D structures of artificial proteins.